Literature DB >> 15133813

Enhancing recognition of early Parkinsonism in the community.

Günter U Höglinger1, Ida Rissling, Aline Metz, Vincent Ries, Anne Heinermann, Helge Prinz, Sybille Spieker, Günter Deuschl, Erika Baum, Wolfgang H Oertel.   

Abstract

Because Parkinsonism is underdiagnosed in the community, we have validated screening modalities in the field setting and developed a screening procedure to enhance recognition of undiagnosed patients. In a first survey, we identified suspect cases among patients consulting 9 general practitioners (GPs) over a 3-week period using in parallel: (1) a published questionnaire; (2) a standardized examination by the GPs; (3) clinical impression of the GPs; or (4) pre-established diagnoses. Parkinsonism was ascertained by two neurologists with a 1-year follow-up and FP-CIT-SPECT. In total, 1,411 patients consulted the GPs, 1,030 participated in the study, 87 possible cases were identified by at least one of four screening modalities, 12 suffered from Parkinsonism, and 4 of these 12 were de novo cases. Statistical analysis demonstrated that with appropriate evaluation, the questionnaire is highly sensitive and excludes most nonaffected persons, and that the GPs' clinical impression is more specific. We therefore tested in a second survey the efficacy of a serial screening, starting with the questionnaire, followed by a standardized GP evaluation, and then by neurological examination. Of 1,353 participants seen by 9 GPs during a 3-week period, 5 de novo cases were identified. This simple screening protocol significantly enhances recognition of incipient Parkinsonism. Copyright 2004 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133813     DOI: 10.1002/mds.20033

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  6 in total

Review 1.  Screening questionnaires for parkinsonism: a systematic review.

Authors:  Nabila Dahodwala; Andrew Siderowf; Mona Baumgarten; Aaron Abrams; Jason Karlawish
Journal:  Parkinsonism Relat Disord       Date:  2011-09-17       Impact factor: 4.891

2.  [Multimorbidity and successful aging: the population-based KORA-Age study].

Authors:  A Peters; A Döring; K-H Ladwig; C Meisinger; B Linkohr; C Autenrieth; S E Baumeister; J Behr; A Bergner; H Bickel; M Bidlingmaier; A Dias; R T Emeny; B Fischer; E Grill; L Gorzelniak; H Hänsch; S Heidbreder; M Heier; A Horsch; D Huber; R M Huber; R A Jörres; S Kääb; S Karrasch; I Kirchberger; G Klug; B Kranz; B Kuch; M E Lacruz; O Lang; A Mielck; D Nowak; S Perz; A Schneider; H Schulz; M Müller; H Seidl; R Strobl; B Thorand; R Wende; W Weidenhammer; A-K Zimmermann; H-E Wichmann; R Holle
Journal:  Z Gerontol Geriatr       Date:  2011-12       Impact factor: 1.281

3.  Primary health care providers' knowledge gaps on Parkinson's disease.

Authors:  Megan R Thompson; Ramona F Stone; V Dan Ochs; Irene Litvan
Journal:  Educ Gerontol       Date:  2013-08-12

4.  Can a screening questionnaire accurately identify mild Parkinsonian signs?

Authors:  Nabila Dahodwala; Lee Kubersky; Andrew Siderowf
Journal:  Neuroepidemiology       Date:  2012-08-29       Impact factor: 3.282

5.  Self-reported parkinsonian symptoms in the EPIC-Norfolk cohort.

Authors:  Lianna S Ishihara; Kay-Tee Khaw; Robert Luben; Sheila Bingham; Ailsa Welch; Nicholas Day; Carol Brayne
Journal:  BMC Neurol       Date:  2005-08-24       Impact factor: 2.474

6.  Parkinson's disease case ascertainment in prospective cohort studies through combining multiple health information resources.

Authors:  Marije Reedijk; Anke Huss; Robert A Verheij; Petra H Peeters; Roel C H Vermeulen
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.